These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 22385716)
1. Randomized clinical trial of weekly versus triweekly cisplatin-based chemotherapy concurrent with radiotherapy in treatment of locally advanced cervical cancer: in regard to Ryu et al. (Int J Radiat Oncol Biol Phys 2011;81:e577-e581). Chakraborty S; Patil N Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1320-1. PubMed ID: 22385716 [No Abstract] [Full Text] [Related]
2. Randomized clinical trial of weekly vs. triweekly cisplatin-based chemotherapy concurrent with radiotherapy in the treatment of locally advanced cervical cancer: in regard to Sang-Young Ryu et al. (Int J Radiat Oncol Biol Phys 2011;81:e577-e581). Goel S; Mitra S; Rawat S; Sharma SK; Sharma MK; Bhutani R; Kakria A Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1320. PubMed ID: 22385715 [No Abstract] [Full Text] [Related]
3. Randomized clinical trial of weekly vs. triweekly cisplatin-based chemotherapy concurrent with radiotherapy in the treatment of locally advanced cervical cancer. Ryu SY; Lee WM; Kim K; Park SI; Kim BJ; Kim MH; Choi SC; Cho CK; Nam BH; Lee ED Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e577-81. PubMed ID: 21840137 [TBL] [Abstract][Full Text] [Related]
4. Concurrent weekly cisplatin and radiotherapy in routine management of cervical cancer: a report on patient compliance and acute toxicity. Serkies K; Jassem J Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):814-21. PubMed ID: 15465198 [TBL] [Abstract][Full Text] [Related]
5. Weekly Versus Triweekly Cisplatin-Based Chemotherapy Concurrent With Radiotherapy in the Treatment of Cervical Cancer: A Meta-Analysis. Chen X; Zou H; Li H; Lin R; Su M; Zhang W; Zhou Y; Zhang P; Hou M; Deng X; Zou C Int J Gynecol Cancer; 2017 Feb; 27(2):344-349. PubMed ID: 27984377 [TBL] [Abstract][Full Text] [Related]
6. Concurrent weekly cisplatin plus external beam radiotherapy and high-dose rate brachytherapy for advanced cervical cancer: a control cohort comparison with radiation alone on treatment outcome and complications. Chen SW; Liang JA; Hung YC; Yeh LS; Chang WC; Lin WC; Yang SN; Lin FJ Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1370-7. PubMed ID: 16979836 [TBL] [Abstract][Full Text] [Related]
7. Current state-of-the-art of concomitant chemoradiation in cervical carcinomas. Vrdoljak E; Hamm W Eur J Gynaecol Oncol; 2003; 24(6):475-9. PubMed ID: 14658585 [TBL] [Abstract][Full Text] [Related]
8. Concurrent weekly cisplatin versus triweekly cisplatin with radiotherapy for locally advanced squamous-cell carcinoma of the cervix: a retrospective analysis from a single institution. Kinjyo Y; Nagai Y; Toita T; Kudaka W; Ariga T; Shimoji Y; Nakasone T; Taira Y; Arakaki Y; Nakamoto T; Wakayama A; Ooyama T; Maemoto H; Heianna J; Aoki Y Br J Radiol; 2017 Aug; 90(1076):20170241. PubMed ID: 28707541 [TBL] [Abstract][Full Text] [Related]
9. Weekly cisplatin therapy compared with triweekly combination chemotherapy as concurrent adjuvant chemoradiation therapy after radical hysterectomy for cervical cancer. Lee HN; Lee KH; Lee DW; Lee YS; Park EK; Park JS Int J Gynecol Cancer; 2011 Jan; 21(1):128-36. PubMed ID: 21330837 [TBL] [Abstract][Full Text] [Related]
10. Concurrent weekly cisplatin versus triweekly cisplatin with radiotherapy in the treatment of cervical cancer: a meta-analysis result. Hu Y; Cai ZQ; Su XY Asian Pac J Cancer Prev; 2012; 13(9):4301-4. PubMed ID: 23167332 [TBL] [Abstract][Full Text] [Related]
11. [Pelvic radiation with concurrent chemotherapy compared with pelvi and para-aortic radiation for high-risk cervical cancer. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. Cisplatin, radiation, and adjuvant hysterectomy for bulky stage Ib cervical carcinoma]. Nöel G; Mazeron JJ Cancer Radiother; 1999; 3(4):345-7. PubMed ID: 10515699 [No Abstract] [Full Text] [Related]
12. Simultaneous radiochemotherapy in cervical cancer: recommendations for chemotherapy. Dunst J; Haensgen G Strahlenther Onkol; 2001 Dec; 177(12):635-40. PubMed ID: 11789401 [TBL] [Abstract][Full Text] [Related]
13. Clinical outcomes of definitive intensity-modulated radiation therapy with fluorodeoxyglucose-positron emission tomography simulation in patients with locally advanced cervical cancer. In regard to Kidd et al. (Int J Radiat Oncol Biol Phys 2010;77:1085-1091.). Wei L; Shi M Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):636-7; author reply 637. PubMed ID: 20980107 [No Abstract] [Full Text] [Related]
14. Five years' experience treating locally advanced cervical cancer with concurrent chemoradiotherapy and high-dose-rate brachytherapy: results from a single institution. Parker K; Gallop-Evans E; Hanna L; Adams M Int J Radiat Oncol Biol Phys; 2009 May; 74(1):140-6. PubMed ID: 18922646 [TBL] [Abstract][Full Text] [Related]
15. Retrospective Analysis of Concurrent Chemoradiation with Triweekly Cisplatin plus 5-Fluorouracil Versus Weekly Cisplatin in Cervical Cancer. Sonoda K; Yahata H; Ichinoe A; Okugawa K; Kaneki E; Kawano Y; Kenjo H; Ohgami T; Yagi H; Ohga S; Asai K; Nakamura K; Honda H; Kato K Anticancer Res; 2015 Jun; 35(6):3447-54. PubMed ID: 26026109 [TBL] [Abstract][Full Text] [Related]
16. In regard to Ishikawa et al.: Cyclooxygenase-2 impairs treatment effect of radiotherapy for cervical cancer by inhibition of radiation-induced apoptosis (Int J Radiat Oncol Biol Phys 2006;66:1347-1355). Herrera FG; Fyles A; Milosevic M Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):959-60; author reply 960. PubMed ID: 17544005 [No Abstract] [Full Text] [Related]
17. Extended-field radiotherapy and high-dose-rate brachytherapy with concurrent and adjuvant cisplatin-based chemotherapy for locally advanced cervical cancer: a phase I/II study. Chung YL; Jian JJ; Cheng SH; Hsieh CI; Tan TD; Chang HJ; Hung CF; Horng CF; Soong T; Tsou MH Gynecol Oncol; 2005 Apr; 97(1):126-35. PubMed ID: 15790448 [TBL] [Abstract][Full Text] [Related]
18. A retrospective review of 15 years of radical radiotherapy with or without concurrent cisplatin and/or 5-fluorouracil for the treatment of locally advanced cervical cancer. Borowsky ME; Elliott KS; Pezzullo JC; Santoso P; Choi W; Choi K; Abulafia O Bull Cancer; 2005 Feb; 92(2):E19-24. PubMed ID: 15749639 [TBL] [Abstract][Full Text] [Related]
19. Weekly versus three-weekly cisplatin as an adjunct to radiation therapy in high-risk stage I-IIA cervical cancer after surgery: a randomized comparison of treatment compliance. Chumworathayi B; Suprasert P; Charoenkwan K; Srisomboon J; Phongnarisorn C; Siriaree S; Cheewakriangkrai C; Tantipalakorn J; Kiatpeerakul C; Pantusart A J Med Assoc Thai; 2005 Nov; 88(11):1483-92. PubMed ID: 16471090 [TBL] [Abstract][Full Text] [Related]
20. In regards to Arcangeli et al. (Int J Radiat Oncol Biol Phys 2006;64:161-167). Munshi A; Jalali R; Budrukar A Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):632; author reply 632-3. PubMed ID: 16690446 [No Abstract] [Full Text] [Related] [Next] [New Search]